BeiGene Ltd Ordinary Shares 06160
News
Global Oncology Innovator BeiGene Appoints Shalini Sharp to Board of Directors
BeiGene Announces Updates to Commercial Leadership Team
BeiGene to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
BeiGene’s BGB-16673 Receives U.S. FDA Fast Track Designation for CLL/SLL
BeiGene Enters Next Phase of Global Growth with Announcement of Second Quarter 2024 Financial Results and Corporate Updates
BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility, Continues Global Expansion to Deliver Medicines to More Patients Around the World
BeiGene Announces Appointment of Aaron Rosenberg as Chief Financial Officer